Skip to main
IPCI

Intellipharmaceutics (IPCI) Market Capitalization Overview

Market Cap: $0.00 as of Feb 20, 2026

$0.00
As of Feb 20, 2026, Intellipharmaceutics (IPCI) has a market capitalization of $0.00. Over the past 30 days, its market cap has increased by 0%, while in the last 12 months, it has increased by 0%.

Market capitalization represents the total value of Intellipharmaceutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Intellipharmaceutics (IPCI) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Intellipharmaceutics (IPCI) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Intellipharmaceutics (IPCI) Market Cap History

DateMarket CapChange
Jan 2, 2025$0.000.00%

Intellipharmaceutics (IPCI) End of Year Market Cap History

DateMarket CapChange
2026$0.000.00%
2025$0.000.00%
2024$0.00-100.00%
2023$2.13M-8.48%
2022$2.33M-44.10%
2021$4.16M

FAQs About Intellipharmaceutics (IPCI) Market Cap

As of Feb 20, 2026, the market capitalization of Intellipharmaceutics (IPCI) is $0.00. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Intellipharmaceutics’s market capitalization has increased by —, changing from – to $0.00 as of Feb 20, 2026.

In the last 3 months, Intellipharmaceutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Intellipharmaceutics’s market capitalization increased from – in January to $0.00 in December, reflecting a 0% change.

Intellipharmaceutics (IPCI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.